Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

14.89
-0.3500-2.30%
Post-market: 14.890.00000.00%16:47 EDT
Volume:955.85K
Turnover:14.31M
Market Cap:2.60B
PE:-5.25
High:15.36
Open:15.26
Low:14.81
Close:15.24
52wk High:34.47
52wk Low:12.72
Shares:174.32M
Float Shares:66.98M
Volume Ratio:0.76
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8352
EPS(LYR):-2.7303
ROE:-77.58%
ROA:-47.07%
PB:4.27
PE(LYR):-5.45

Loading ...

Immunovant’s IMVT-1402: A Promising Solution for Unmet Needs in Graves’ Disease

TIPRANKS
·
Jun 26

Law Firm Launches Investigation into Immunovant Inc. Over Alleged Fiduciary Breaches in Private Placement Deal

Reuters
·
Jun 21

Immunovant Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 30

Guggenheim Reaffirms Their Buy Rating on Immunovant (IMVT)

TIPRANKS
·
May 30

Immunovant price target lowered to $35 from $51 at H.C. Wainwright

TIPRANKS
·
May 30

Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Immunovant (IMVT) and Roivant Sciences (ROIV)

TIPRANKS
·
May 30

Immunovant's Fiscal Q4 Net Loss Widens

MT Newswires Live
·
May 29

Immunovant reports Q4 EPS (64c), consensus (72c)

TIPRANKS
·
May 29

Immunovant Q4 EPS $(0.64) Beats $(0.73) Estimate

Benzinga
·
May 29

BRIEF-Immunovant Q4 Net Income USD -106.449 Million

Reuters
·
May 29

Press Release: Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025

Dow Jones
·
May 29

Immunovant Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
May 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 22

Roivant Sciences Ltd. (ROIV): Among David Einhorn’s Stock Picks with Huge Upside Potential

Insider Monkey
·
May 02

Immunovant Cut to Neutral From Buy by UBS

Dow Jones
·
Apr 22

UBS Downgrades Immunovant to Neutral, Price Target is $17

MT Newswires Live
·
Apr 22

Immunovant downgraded to Neutral from Buy at UBS

TIPRANKS
·
Apr 22

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Caution Deepens Amid Intensifying Tariff Escalations

MT Newswires Live
·
Apr 21

Immunovant Names New CEO, CFO

MT Newswires Live
·
Apr 21